About
Overview
About
Overview
Transforming lives with therapeutic acute wound care
AVITA Medical® is a is a leading therapeutic acute wound care company delivering transformative solutions. Our technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of our platform is the RECELL® System, approved by the U.S. Food and Drug Administration for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin™ cells, offering an innovative solution for improved clinical outcomes at the point of care. In the U.S., AVITA Medical also holds the exclusive rights to manufacture, market, sell, and distribute PermeaDerm®, a biosynthetic wound matrix, and the exclusive rights to market, sell, and distribute Cohealyx™, an AVITA Medical-branded collagen-based dermal matrix.
In international markets, the RECELL System is approved to promote skin healing in a wide range of applications including burns and full-thickness skin defects. The RECELL System, excluding RECELL GO®, is TGA-registered in Australia, has received CE mark approval in Europe, and has PMDA approval in Japan.

Our Values
We believe that patients are at the heart of everything we do.
We believe that our employees are the lifeblood of AVITA Medical.
We believe that passion is key to making a difference at AVITA Medical.
We believe that quality impacts everything we do.
We believe that integrity is essential to our success.
By the numbers
NUMBER
OF
EMPLOYEES
RANDOMIZED
CONTROL
TRIALS
PUBLICATIONS
AND
PRESENTATIONS
TREATED
WORLDWIDE
At AVITA Medical, patients are at the center of everything we do.
They guide and inspire our tireless commitment to advancing bold innovation in acute wound care, delivering medical outcomes that transform lives.